Bipolar Medications: Mechanisms of Action by American Psychiatric Association Publishing (Hardback, 2000)
Brand newLOWEST PRICE
- AU $162.20+ AU $10.00 postage
- Brand new condition
- Sold by roxy*books
- See details for delivery est.
- AU $32.44+ AU $4.99 postage
- Good condition
- Sold by whattaplace
- See details for delivery est.
All listings for this product
Best-selling in Textbooks
Save on Textbooks
- AU $37.79Trending at AU $65.19
- AU $68.00Trending at AU $71.53
- AU $105.99Trending at AU $107.61
- AU $100.89Trending at AU $103.04
- AU $68.00Trending at AU $80.61
- AU $105.90Trending at AU $116.86
- AU $110.99Trending at AU $112.12
About this product
- DescriptionLithium, the treatment of choice for mania since its usefulness was first reported, has been shown to have varied effects on multiple biological systems, including electrolyte flux and neurochemistry. Recent advances in cellular and molecular biology promise to provide clinicians with a better understanding of the etiology of bipolar disorder and new options for treatment. Bipolar Medications: Mechanisms of Action presents the treatment and prophylaxis of bipolar disorder. More than 40 investigators share research and insight into the neurobiological mechanisms that help to explain the powerful effects of new antibipolar drugs. This comprehensive text * Examines valproic acid, lamotrigine, isitol mophosphatase inhibitors, and protein kinase C inhibitors that have the potential to revolutionize clinical practice and provide new hypotheses on the etiology of bipolar disorder * Presents the current understanding of the cellular mechanisms of action of mood-stabilizing agents * Discusses the emergence of valproate as a powerful lithium alternative and examines the preliminary indications that lamotrigine will be an effective option * Examines the issue of withdrawal rebound, which can make lithium ineffective or even counterproductive, and reviews isitol mophosphatase inhibitors that mimic lithium action in patients * Compares lithium, carbamazepine, and valproate and their differential mechanisms, which could form the basis of a rational polypharmacy of manic depressive illness * Examines behavioral models important in the screening of new antibipolar compounds and the effects of antibipolar compounds on immediate early genes Complete with extensive references, tables, and figures, this text is essential reading for any clinician who treats patients with bipolar disorder. It thoroughly documents the latest in psychopharmacology, as well as projecting future advances in the treatment of bipolar disorder.
- Author BiographyHusseini K. Manji, M.D., F.R.C.P.C., is Director of the Laboratory of Molecular Pathophysiology in the Department of Psychiatry and Behavioral Neurosciences at Wayne State University School of Medicine in Detroit, Michigan. Charles L. Bowden, M.D., is the Nancy U. Karren Professor and Interim Chair of the Department of Psychiatry at the University of Texas Health Science Center at San Antonio, In San Antonio, Texas. Robert H. Belmaker, M.D., is Hoffer-Vickar Professor of Psychiatry at Beer Sheva Mental Health Center and on the Faculty of Health Sciences at the Ben Gurion University of the Negev in Beersheva, Israel.
- PublisherAmerican Psychiatric Association Publishing
- Date of Publication01/03/2000
- SubjectClinical Medicine: Professional
- Place of PublicationVA
- Country of PublicationUnited States
- ImprintAmerican Psychiatric Press Inc.
- Content Noteindex
- Weight907 g
- Width152 mm
- Height229 mm
- Spine31 mm
- Edited byCharles L. Bowden,Husseini K. Manji,Robert H. Belmaker
This item doesn't belong on this page.
Thanks, we'll look into this.